Guillain-Barré syndrome: Possible complication of the flu vaccine?

Authors

  • Mª Cristina Alfaro Royo
  • Mª Carmen Zaragozà Biot
  • Juan Navarro Guillén
  • Oscar Fernández Alquézar
  • Carmen Natividad Cárdenas Beltrán
  • Rocío Sánchez Miguel

Keywords:

Guillain-Barré syndrome; Flu vaccine; Research protocol

Abstract

Objectives: The objective of this article is to establish a research protocol to determine if there is an association between the flu vaccine and Guillain-Barré Syndrome (GBS).

Methods: A case-control study will be carried out to determine whether or not there is a relationship between the flu vaccine and the GBS. For each case of GBS a control of the same sex and of similar age will be selected, and it will be determined if they have been exposed to the flu vaccine, in order to determine whether this vaccine increases the risk of suffering from GBS.

Findings: The flu vaccine is not expected to be associated with an increased risk of GBS. Such a result would be of great importance for the patients and for the healthcare system. It would contribute decisively to reassure the general population, especially the risk groups that can benefit from flu vaccine, being able to inform them of its safety.

Conclusions: It is recommended to carry out this protocol in different health centers to obtain reliable conclusions about the possible association between flu vaccine and GBS.

 

Downloads

Download data is not yet available.

References

Organización Mundial de la Salud. Gripe (estacional). [Internet]. Ginebra: OMS; 2018 [cited 2019 Oct 11]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/influenza-(seasonal)

Moreno-Pérez D, Álvarez García FJ, Arístegui Fernandez J, Merino Molina M, Ruiz Contreras J, Cilleruelo Ortega MJ, et al. Vacunación frente a la gripe estacional en la infancia y la adolescencia. Recomendaciones del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP) para la campaña antigripal 2016-2017. Rev Pediatr Aten Primaria. 2016;18:e173-e197.

González C. En Defensa de las Vacunas. Madrid: Editorial Planeta; 2011.

Sarria A, Timoner J. Determinantes de la vacunación de la gripe en personas mayores de 65 años. Revista Española de Salud Pública. 2002;76(1):17-26.

Sánchez-Payá J, Hernández-García I, Barrenengoa-Sañudo J, Camargo-Ángeles R, Rincón A, Romero-Candeira S. Frecuencia de reacciones adversas y factores asociados tras la administración de la vacuna de la gripe en personal sanitario durante la temporada 2009-2010. Rev Esp Salud Pública. 2010;85(6):851-854.

Martin Moreno V, Molina Cabrerizo MR, Sotillo Rincón MJ, Gómez Gómez C, Álvarez Gómez J. Efectos adversos asociados a la vacunación antigripal en pediatría. Rev Esp de Salud Pública. 1998;72(4):319-329.

Trilla A. Seguridad y efectividad de la vacuna antigripal: Nuevos datos, nuevos retos. Medicina Clínica. 2013;141(2):67-69. https://doi.org/10.1016/j.medcli.2013.04.011

Haber P, DeStefano F, Angulo F, Iskander J, Sean V, Shadomy S, et al. Guillain- Barré syndrome following influenza vaccination. Jama. 2004;292(20):2478-2481. https://doi.org/10.1001/jama.292.20.2478

Picazo JJ, Alonso Suárez LM, Arístegui Fernández J, Bayas Rodríguez JM, Sanz Villorejo J, del Amo Merino P, et al. Consenso sobre la vacunación frente a la gripe en el personal sanitario. Revista Española de Quimioterapia. 2012;25(3):226-239.

Puga Torres Mario S, Padrón Sánchez A, Bravo Pérez R. Síndrome de Guillain Barré. Rev Cubana Med Milit. 2003;32(2):137-142.

Múñiz Saitua J. Colectivos antivacunas: Objetivos, estrategias e impacto. En: Jornadas de Vacunas de la A.E.P 2011. 24 y 25 de marzo de 2011, Sevilla. Barcelona: Grupo pacífico; 2011. p. 12-14.

Linde P. Quienes son los antivacunas [Internet]. Madrid: El País; 2015 [cited 2019 Oct 15]. Available from: http://elpais.com/elpais/2015/06/02/planeta_futuro/1433262146_575760.html

Brown D. Pandemia no hay ninguna: ¡Detengan la Vacuna! [Internet]. 2009 [cited Oct 15]. Available from: https://detenganlavacuna.wordpress.com/tag/gripe-porcina/page/17/

Vargas Herrera J. La seguridad de las vacunas: Un tema importante para la población. Revista Peruana de Medicina Experimental y Salud Pública. 2006;23(1):3-4.

Wolfe RM, Sharp LK, Lipsky MS. Content and design attributes of antivaccination web sites. Jama. 2002;287(24):3245-3248. http://dx.doi.org/10.1001/jama.287.24.3245

Rainie L, Fox S. Pew Research Center. The online Helath Care Revolution [Internet]. 2000 [cited 2019 Oct 15]. Available from: http://www.pewinternet.org/2000/11/26/the-online-health-care-revolution/

Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United Stated, 2015-2016 Influenza Season. MMWR Morb Mortal Wkly Rep. 2015;64(30):818-825.

Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M. Vacunas contra la gripe en adultos con cáncer e inmunodeprimidos. Cochrane Database of Systematic Reviews. 2003;1-11. https://doi.org/10.1002/14651858.CD008983.pub2

Kumate-Rodriguez J. Pandemia de Influenza A (H1N1). Cirugía y Cirujanos. 2009;77(3):165-166.

Acuña L. Influenza: Historia y amenazas. Rev Chil Infect. 2004;21(2):162-164. http://dx.doi.org/10.4067/S0716-10182004000200012

Ministerio de Sanidad, Política Social e Igualdad. Serie: Información y Estadísticas Sanitarias. Clasificación internacional de enfermedades. [Internet]. Madrid: 2012 [cited 2019 Oct 14]. Available from: https://www.mscbs.gob.es/estadEstudios/estadisticas/normalizacion/clasifEnferm/home.htm

Asociación Española de Pediatría: Comité Asesor de Vacunas. Recomendaciones de vacunación frente a la gripe 2019-20 [Internet]. 2019. [cited 2019 Oct 14]. Available from: https://vacunasaep.org/documentos/recomendaciones-de-vacunacion-frente-la-gripe-2019-20

Ministerio de Sanidad, Consumo y Bienestar Social. Coberturas de Vacunación: Datos Estadísticos [Internet]. 2019 [cited 2019 Oct 15]. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/coberturas.htm

Downloads

Published

2019-12-09

How to Cite

Alfaro Royo, M. C. ., Zaragozà Biot, M. C. ., Navarro Guillén, J., Fernández Alquézar, O. ., Cárdenas Beltrán, C. N. ., & Sánchez Miguel, R. . (2019). Guillain-Barré syndrome: Possible complication of the flu vaccine?. Atena Journal of Public Health, 1, 3. Retrieved from https://atenajournals.com/index.php/ajph/article/view/10

Issue

Vol. 1 (2019)

Section

Articles

License

Copyright and Licensing

For all articles published in Atena Journals, copyright is retained by the authors. Articles are licensed under an open access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. These conditions allow for maximum use and exposure of the work, while ensuring that the authors receive proper credit.

Reproducing Published Material from other Publishers

It is absolutely essential that authors obtain permission to reproduce any published material (figures, schemes, tables or any extract of a text) which does not fall into the public domain, or for which they do not hold the copyright. Permission should be requested by the authors from the copyrightholder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyrightholder).

Permission is required for:

  1. Your own works published by other Publishers and for which you did not retain copyright.
  2. Substantial extracts from anyones' works or a series of works.
  3. Use of Tables, Graphs, Charts, Schemes and Artworks if they are unaltered or slightly modified.
  4. Photographs for which you do not hold copyright.

Permission is not required for:

  1. Reconstruction of your own table with data already published elsewhere. Please notice that in this case you must cite the source of the data in the form of either "Data from..." or "Adapted from...".
  2. Reasonably short quotes are considered fair use and therefore do not require permission.
  3. Graphs, Charts, Schemes and Artworks that are completely redrawn by the authors and significantly changed beyond recognition do not require permission.

Obtaining Permission

In order to avoid unnecessary delays in the publication process, you should start obtaining permissions as early as possible. If in any doubt about the copyright, apply for permission. Atena Journals cannot publish material from other publications without permission.

The copyright holder may give you instructions on the form of acknowledgement to be followed; otherwise follow the style: "Reproduced with permission from [author], [book/journal title]; published by [publisher], [year].' at the end of the caption of the Table, Figure or Scheme.